Biora Therapeutics Inc (NAS:BIOR)
$ 0.678 0.02 (3.04%) Market Cap: 24.73 Mil Enterprise Value: 66.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q4 2021 Progenity Inc Earnings Call Transcript

Mar 28, 2022 / 08:30PM GMT
Release Date Price: $40.25 (-4.73%)
Operator

Greetings, and welcome to the Progenity Fourth Quarter and Full Year 2021 Earnings Call. (Operator Instructions)

As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Chuck Padala, Managing Director with LifeSci Advisors.

Chuck Padala

Thank you, operator. Good afternoon and welcome to Progenity's fourth quarter 2021 corporate update and financial results conference call. Joining me on the call are Aditya Mohanty, Chief Executive Officer of Progenity; and Eric d'Esparbes, Chief Financial Officer. Before I turn the call up to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking statements in our annual report and Form 10-K that we will file later today and our subsequent periodic reports filed with the SEC, which will be available on our website in the Investors section. These forward-looking statements represent our views only as of the date

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot